It’s springtime in a non-election year. A time to decompress from political commentary, prep for Fourth of July parties, and gear up for summer vacations. But a funny thing happened on the way to sun and fun, in one of the world’s most desirable vacation spots: San Diego County Supervisor Nora Vargas, re-elected by voters just last fall, unexpectedly resigned shortly thereafter.
A new federal enforcement deadline is set to reshape access to some of the country’s most in-demand weight-loss drugs. Starting May 22, the U.S. Food and Drug Administration (FDA) will prohibit most pharmacies and providers from producing or distributing compounded versions of GLP-1 medications semaglutide and tirzepatide, active ingredients in blockbuster drugs including Ozempic, Wegovy, Mounjaro, and Zepbound.